Skip to content

SCHEDULE 13D/AAccepted Nov 17, 4:22 PM ET

Marker Therapeutics, Inc. SCHEDULE 13D/A

New Enterprise Associates 16, L.P.

Accepted (ET)

4:22 PM

Nov 17, 2025

Filed

Nov 17, 2025

Documents

3

Size

79.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.